FdaApplication
ANDA 205057
Identifiers
- fda_app_no: ANDA205057
Properties
| Property | Value |
|---|---|
| applicant_name | HIKMA PHARMS |
| application_type | ANDA |
| approval_date | 2026-02-10 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TAPENTADOL HYDROCHLORIDE | TAPENTADOL HYDROCHLORIDE | EQ 50MG BASE | TABLET;ORAL |
| TAPENTADOL HYDROCHLORIDE | TAPENTADOL HYDROCHLORIDE | EQ 100MG BASE | TABLET;ORAL |
| TAPENTADOL HYDROCHLORIDE | TAPENTADOL HYDROCHLORIDE | EQ 75MG BASE | TABLET;ORAL |
3 products